SMAD4 (SMAD Family Member 4) is the central co-mediator of TGF-beta signaling in the nervous system. This protein partners with receptor-regulated SMADs (SMAD2, SMAD3) to transduce TGF-beta signals from the cell surface to the nucleus, regulating gene expression programs that control neuroinflammation, neuronal survival, and synaptic plasticity.
Overview
SMAD4 (also known as DPC4 - Deleted in Pancreatic Cancer 4) is a 552 amino acid protein that serves as the central mediator of canonical TGF-beta signaling[@massague2000]. Unlike other SMADs, SMAD4 is not a direct substrate of TGF-beta receptors; instead, it forms heteromeric complexes with phosphorylated SMAD2/SMAD3 to regulate transcription of target genes[@heldin2021].
Protein Information
Protein Structure
MH1 Domain (1-150 aa)
DNA-binding domain: Recognizes SMAD-binding elements (SBE) with consensus sequence GTCTAGAC
The study of Smad4 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
External Links
[PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
[Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
[Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data
References
Massague J, TGF-beta signal transduction (2000)
Heldin CH, et al, TGF-beta signaling mechanisms (2021)
Brionne TC, et al, Loss of TGF-beta signaling in neurons (2021)
Kane CJ, et al, TGF-beta neuroprotection in PD (2018)
Ferguson L, et al, TGF-beta and synaptic plasticity (2019)
Wrana JL, et al, Smad4 transcriptional regulation (2019)
Caraci F, et al, TGF-beta alterations in AD (2021)
Wyss-Coray T, et al, TGF-beta and APP processing (2020)
Tolar M, et al, TGF-beta and neuroinflammation in AD (2020)
Rai SN, et al, TGF-beta protection in dopaminergic neurons (2022)